CN1058407C - Medicament for treating gastropathy - Google Patents
Medicament for treating gastropathy Download PDFInfo
- Publication number
- CN1058407C CN1058407C CN96115541A CN96115541A CN1058407C CN 1058407 C CN1058407 C CN 1058407C CN 96115541 A CN96115541 A CN 96115541A CN 96115541 A CN96115541 A CN 96115541A CN 1058407 C CN1058407 C CN 1058407C
- Authority
- CN
- China
- Prior art keywords
- medicine
- gastropathy
- common
- flavoprotein
- skullcap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Gastropathy, which obsesses human beings, is a common disease and a frequently encountered disease. Conventional therapies mainly use an antacid, but serial side effect is brought. The present invention provides gastropathy treating medicine combining traditional Chinese medicine and western medicine, namely Weijing which has a prescription comprising the components of 8 to 16 of skullcap, 8 to 16 of phellodendron bark, 6 to 14 of coptis, 8 to 16 of common aucklandia root and 0.005 to 0.02 of flavoprotein prosthetic group according to the weight ratio. Skullcap, phellodendron bark and coptis have strong sterilization action on helicobacter pylori inducing gastropathy; common aucklandia root can promote qi circulation to relieve pain; flavoprotein can obviously increase therapeutic effect. Clinic statistics indicate that the total effective rate of the medicine can reach more than 94%.
Description
The invention belongs to medicine field, particularly treat the medicine of gastropathy.
Gastropathy is human commonly encountered diseases, frequently-occurring disease.Antiacid treatment is one of the most classical, effective method of Peptic Ulcers, gastritis so far.
From five, the Xiao Su in the sixties reaches, aluminium hydroxide, magnesium oxide.To the cimetidine of the seventies, the ranitidine of the eighties, omeprazole has been arranged again now, the antiacid action intensity of these medicines is becoming Radix Achyranthis Bidentatae ground to increase.But these medicines have also brought a series of side effect: along with the normal gastric acid secretion function of human body is suppressed, the rhythm and pace of moving things is upset, the inclined to one side alkali of gastric juice, the bactericidal action of gastric juice is weakened and even disappear, and makes the source of disease microorganism undue growth that upper digestive tract etc. is located, thereby causes many infection.Someone finds, 20% stomach, duodenal ulcer, gastritis patient, take cimetidine after curative effect have a rebound, or protracted course of disease presses down acid and too can invite a wolf into house.
The purpose of this invention is to provide and a kind ofly add the made Chinese and Western of yellow enzyme prothetic group in conjunction with new drug, do not add any sour composition that presses down, be used for the treatment of various types of gastritis, gastric and duodenal ulcers by kinds of traditional Chinese medicines (SANHUANG and the Radix Aucklandiae).
Another object of the present invention provides the bonded method of this Chinese medicine and western medicine of making.
Stomach according to treatment gastropathy of the present invention is clean, includes Radix Scutellariae, Rhizoma Coptidis, Cortex Phellodendri, the Radix Aucklandiae and yellow enzyme prothetic group.Its proportioning is (weight ratio): Radix Scutellariae: Cortex Phellodendri: Rhizoma Coptidis: the Radix Aucklandiae: yellow enzyme prothetic group=8～16: 8～16: 6～14: 8～16: 0.005～0.02.
In the pharmaceutical formulation according to treatment gastropathy of the present invention, main component Chinese medicine " SANHUANG " is that the pharmacological action of Radix Scutellariae, Cortex Phellodendri, Rhizoma Coptidis is heat clearing away, dampness, pathogenic fire purging, detoxifcation, and the helicobacter pylori that causes stomachache is had stronger bactericidal action." SANHUANG " drug combination, synergism strengthens." SANHUANG " intersection is selected its two kinds, the while 5 usefulness Radix Aucklandiae, yellow enzyme prothetic group, and its curative effect is starkly lower than " SANHUANG " use in conjunction.The pharmacological action of the Radix Aucklandiae is promoting the circulation of QI to relieve pain.The pharmacological action of yellow enzyme prothetic group: storage capacity is seldom in human body for yellow enzyme, and very easily be subjected to the influence of various factors and destroy, common symptom was lip, angular cheilitis, eczema scrotum, pharyngitis, esophagitis etc. when human body lacked yellow enzyme, also might cause gastritis, gastric and duodenal ulcers.In the stomach medicine, add micro-yellow enzyme prothetic group, can significantly improve the effective percentage of treatment, clinical statistics shows that total effective rate can bring up to 94% from 65%.
Clinical trial shows that medicine total effective rate of the present invention reaches 94%, and pylorus screw rod elimination factor is reached 100%.
Manufacture method according to the medicine of treatment gastropathy of the present invention is: will pulverize according to the prepared slices of Chinese crude drugs of prescription of the present invention, and soak into sterile distilled water, after 8 layers of filtered through gauze, send the drying baker dry sterilization, select the essence, add yellow enzyme prothetic group powder, make tablet then, the watered pill or capsule.Instructions about how to take medicine and dosage: oral, every day three times, each 5g.
Embodiment:
Example 1: adopt following prescription (weight ratio): Radix Scutellariae: Cortex Phellodendri: Rhizoma Coptidis: the Radix Aucklandiae: yellow enzyme prothetic group=10: 10: 8: 10: 0.01, make medicine of the present invention.
Example 2: it is clean to adopt following prescription (weight ratio) to make stomach: Radix Scutellariae: Cortex Phellodendri: Rhizoma Coptidis: the Radix Aucklandiae: yellow enzyme prothetic group=16: 16: 14: 16: 0.02, make medicine of the present invention.
Clinical data and result.
Utilize stomach medicine of the present invention, in certain hospital 1200 routine gastric and duodenal ulcers, all kinds gastritis sufferer are treated, male patient's 785 examples wherein, female patient 415 examples, age is between 10～76 years old, gastric and duodenal ulcers patient 731 examples, all kinds gastritis sufferer's 469 examples (wherein atrophic gastritis 18 examples).Gastroscopy, barivm meal fluoroscopy (screem) result (do not have gastroscope, gastrointestinal barivm meal fluoroscopy (screem) result's patient not included in) are all arranged before 1200 patient treatments.Sick time is the longest 52 years among the patient, and the shortest time limit 4 months was once taken medicines such as cimetidine, stomach are peaceful, roter tablets, omeprazole, WEILEXIN, all went to a doctor because of poor effect, used stomach medicine of the present invention instead.
In 1200 patients, only treat healing (complete obiteration of gastropathy symptom) person's 823 examples (accounting for 68.6%) through stomach, (the gastropathy symptom disappears produce effects substantially, the gastroscopy focus obviously reduces, diminishes) person's 209 examples, account for 17.4%, improvement person's (gastropathy sx, the gastroscopy focus reduces to some extent) 96 examples account for son 8%.Total effective rate reaches 94%.Gastropathy transference cure, transference cure in the time of 15 days at the latest in medication one day that onset time is the fastest.Most cases transference cure in 2～3 days.Healing person's gastroscopy is many to be carried out in 6～20 days after medication.
Claims (3)
1, a kind of medicine for the treatment of gastropathy is characterized in that what this medicine was made by the following weight proportion raw material: Radix Scutellariae: Cortex Phellodendri: Rhizoma Coptidis: the Radix Aucklandiae: yellow enzyme prothetic group=8～16: 8～16: 6～14: 8～16: 0.005～0.02.
2, according to the medicine of the treatment gastropathy of claim 1, it is characterized in that the formulation weight ratio of this medicine is: Radix Scutellariae: Cortex Phellodendri: Rhizoma Coptidis: the Radix Aucklandiae: yellow enzyme prothetic group=10: 10: 8: 10: 0.01.
3, according to the medicine of the treatment gastropathy of claim 1, it is characterized in that the formulation weight ratio of this medicine is: Radix Scutellariae: Cortex Phellodendri: Rhizoma Coptidis: the Radix Aucklandiae: yellow enzyme prothetic group=16: 16: 14: 16: 0.02.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96115541A CN1058407C (en) | 1996-08-13 | 1996-08-13 | Medicament for treating gastropathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96115541A CN1058407C (en) | 1996-08-13 | 1996-08-13 | Medicament for treating gastropathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1173345A CN1173345A (en) | 1998-02-18 |
| CN1058407C true CN1058407C (en) | 2000-11-15 |
Family
ID=5122782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96115541A Expired - Fee Related CN1058407C (en) | 1996-08-13 | 1996-08-13 | Medicament for treating gastropathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058407C (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1039968A (en) * | 1989-06-14 | 1990-02-28 | 陈江辉 | The compound method of gastritis curing oral liquid |
| CN1049972A (en) * | 1989-09-03 | 1991-03-20 | 谢金臣 | Preparation method of quick-acting capsule for stomach |
| CN1108559A (en) * | 1994-03-12 | 1995-09-20 | 林育方 | Typhoid fever removing medicine |
-
1996
- 1996-08-13 CN CN96115541A patent/CN1058407C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1039968A (en) * | 1989-06-14 | 1990-02-28 | 陈江辉 | The compound method of gastritis curing oral liquid |
| CN1049972A (en) * | 1989-09-03 | 1991-03-20 | 谢金臣 | Preparation method of quick-acting capsule for stomach |
| CN1108559A (en) * | 1994-03-12 | 1995-09-20 | 林育方 | Typhoid fever removing medicine |
Non-Patent Citations (3)
| Title |
|---|
| 《北京中医》(6) 1993.6.30 吴峥，黄连解毒汤的药理研究近况 * |
| 《北京中医》(6) 1993.6.30 吴峥，黄连解毒汤的药理研究近况;《新消化病学杂志》4(4) 1996.4.30 黄永明等，解毒护胃汤治疗胃热型慢性浅性胃炎1040例 * |
| 《新消化病学杂志》4(4) 1996.4.30 黄永明等，解毒护胃汤治疗胃热型慢性浅性胃炎1040例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1173345A (en) | 1998-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102038829A (en) | Medicament for treating gastritis and ulcers of stomachs and duodenums | |
| CN1058407C (en) | Medicament for treating gastropathy | |
| CN101700296B (en) | Chinese herbal preparation for curing gastroenteritis and preparation method thereof | |
| CN101991804B (en) | Externally applied medicament for treating stomach illness | |
| CN104147524A (en) | Traditional Chinese medicine preparation for treating peptic ulcer | |
| CN1061538C (en) | Chinese medicine for stomach diseases | |
| CN1255165C (en) | Traditional Chinese medicinal preparation for treating iternal-external ulcer and its preparation method | |
| CN103550445B (en) | Chinese medicine for treating various diseases | |
| CN1111035C (en) | Kuiyangling as one kind of Chinese medicine for gastroenteritic diseases | |
| CN1088378C (en) | Oral Chinese medicine liquid for treating chronic superficial gastritis and its preparation | |
| CN1277571C (en) | Chinese medicine preparation for stomach diseases | |
| CN112641884B (en) | Composition for repairing gastric mucosa and improving gastric motility and preparation method thereof | |
| CN110339272B (en) | Traditional Chinese medicine composition for treating coronary heart disease and peptic ulcer after PCI (percutaneous coronary intervention) operation and preparation method thereof | |
| CN1072959C (en) | Medicine for treating gastritis, gastric ulcer and duodenal ulcer and its prepn. method | |
| CN106822734A (en) | A kind of numbness relieving and pain relieving externally used medicine bag | |
| CN105031587A (en) | Chinese herba preparation for curing gastrointestinal diseases | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN110960616A (en) | Antibacterial repairing ointment for treating bedsore gangrene and preparation method thereof | |
| CN100364576C (en) | Vagina applied Chinese medicinal preparation for treating profuse leukorrhea and cervical erosion and preparation method thereof | |
| CN1425424A (en) | Specific remedy for curing duodenal and gastric ulcer | |
| CN100435818C (en) | Medicine for treating bone ulcer | |
| CN1465357A (en) | Chinese patent drug for treating chronic gastritis and chronic gastric ulcer | |
| CN1184982C (en) | Ulcer treating capsule and its prepn | |
| CN110201078A (en) | It is a kind of for treating the external-applied ointment and its preparation process of exanthemv | |
| CN100589816C (en) | A fumigant medicine for treating angitis and method for making same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |